ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Net Assets

Latest as of March 2026: CN¥3.43 Billion CNY ≈ $502.55 Million USD

Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has net assets worth CN¥3.43 Billion CNY (≈ $502.55 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.13 Billion ≈ $751.24 Million USD) and total liabilities (CN¥1.70 Billion ≈ $248.69 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of ZhuZhou QianJin Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥3.43 Billion
% of Total Assets	66.9%
Annual Growth Rate	13.82%
5-Year Change	24.08%
10-Year Change	60.77%
Growth Volatility	35.09

ZhuZhou QianJin Pharmaceutical Co Ltd - Net Assets Trend (2001–2025)

This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. See ZhuZhou QianJin Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2025)

The table below shows the annual net assets of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2025. For live valuation and market cap data, see 600479 market cap overview.

Year	Net Assets	Change
2025-12-31	CN¥3.35 Billion ≈ $490.23 Million	+6.72%
2024-12-31	CN¥3.14 Billion ≈ $459.36 Million	+3.71%
2023-12-31	CN¥3.03 Billion ≈ $442.91 Million	+7.93%
2022-12-31	CN¥2.80 Billion ≈ $410.37 Million	+3.87%
2021-12-31	CN¥2.70 Billion ≈ $395.08 Million	-2.25%
2020-12-31	CN¥2.76 Billion ≈ $404.17 Million	+5.04%
2019-12-31	CN¥2.63 Billion ≈ $384.79 Million	+8.21%
2018-12-31	CN¥2.43 Billion ≈ $355.58 Million	+8.42%
2017-12-31	CN¥2.24 Billion ≈ $327.95 Million	+7.55%
2016-12-31	CN¥2.08 Billion ≈ $304.94 Million	+6.10%
2015-12-31	CN¥1.96 Billion ≈ $287.40 Million	+41.73%
2014-12-31	CN¥1.39 Billion ≈ $202.78 Million	+15.06%
2013-12-31	CN¥1.20 Billion ≈ $176.24 Million	+13.19%
2012-12-31	CN¥1.06 Billion ≈ $155.70 Million	+7.09%
2011-12-31	CN¥993.56 Million ≈ $145.39 Million	+5.72%
2010-12-31	CN¥939.81 Million ≈ $137.52 Million	-1.21%
2009-12-31	CN¥951.29 Million ≈ $139.20 Million	+8.63%
2008-12-31	CN¥875.75 Million ≈ $128.15 Million	-2.26%
2007-12-31	CN¥895.95 Million ≈ $131.11 Million	+35.83%
2006-12-31	CN¥659.60 Million ≈ $96.52 Million	+10.89%
2005-12-31	CN¥594.85 Million ≈ $87.05 Million	-7.65%
2004-12-31	CN¥644.15 Million ≈ $94.26 Million	+176.38%
2003-12-31	CN¥233.07 Million ≈ $34.10 Million	+25.60%
2002-12-31	CN¥185.56 Million ≈ $27.15 Million	+23.76%
2001-12-31	CN¥149.94 Million ≈ $21.94 Million	--

Equity Component Analysis

This analysis shows how different components contribute to ZhuZhou QianJin Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2256.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥1.35 Billion	44.60%
Other Components	CN¥1.68 Billion	55.40%
Total Equity	CN¥3.03 Billion	100.00%

ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their market capitalization.

Company	Market Cap
Zhejiang Tiancheng Control Co SHG:603085	$688.58 Million
Greenfire Resources Ltd. NYSE:GFR	$688.61 Million
Kinepolis Group NV BR:KIN	$688.78 Million
Western Asset Diversified Income Fund NYSE:WDI	$688.87 Million
Mega First Corporation Bhd KLSE:3069	$688.47 Million
Ningbo Jianan Electronics Co Ltd SHE:300880	$688.45 Million
Autoneum Holding AG SW:AUTN	$688.43 Million
Shanghai Bolex Food Technology Co. Ltd. SHG:603170	$688.36 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ZhuZhou QianJin Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,462,279,280 to 3,028,298,497, a change of 566,019,217 (23.0%).
Net income of 287,836,839 contributed positively to equity growth.
Dividend payments of 152,678,987 reduced retained earnings.
Other comprehensive income decreased equity by 1,575,287.
Other factors increased equity by 432,436,652.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥287.84 Million	+9.5%
Dividends Paid	CN¥152.68 Million	-5.04%
Other Comprehensive Income	CN¥-1.58 Million	-0.05%
Other Changes	CN¥432.44 Million	+14.28%
Total Change	CN¥-	22.99%

Book Value vs Market Value Analysis

This analysis compares ZhuZhou QianJin Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.42x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 21.52x to 1.42x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2001-12-31	CN¥0.44	CN¥9.56	x
2002-12-31	CN¥0.54	CN¥9.56	x
2003-12-31	CN¥0.71	CN¥9.56	x
2004-12-31	CN¥2.07	CN¥9.56	x
2005-12-31	CN¥1.90	CN¥9.56	x
2006-12-31	CN¥2.10	CN¥9.56	x
2007-12-31	CN¥2.39	CN¥9.56	x
2008-12-31	CN¥2.33	CN¥9.56	x
2009-12-31	CN¥2.53	CN¥9.56	x
2010-12-31	CN¥2.46	CN¥9.56	x
2011-12-31	CN¥2.48	CN¥9.56	x
2012-12-31	CN¥2.64	CN¥9.56	x
2013-12-31	CN¥2.76	CN¥9.56	x
2014-12-31	CN¥3.07	CN¥9.56	x
2015-12-31	CN¥4.30	CN¥9.56	x
2016-12-31	CN¥4.17	CN¥9.56	x
2017-12-31	CN¥4.49	CN¥9.56	x
2018-12-31	CN¥4.85	CN¥9.56	x
2019-12-31	CN¥5.20	CN¥9.56	x
2020-12-31	CN¥5.42	CN¥9.56	x
2021-12-31	CN¥5.14	CN¥9.56	x
2022-12-31	CN¥5.18	CN¥9.56	x
2023-12-31	CN¥5.66	CN¥9.56	x
2024-12-31	CN¥5.95	CN¥9.56	x
2025-12-31	CN¥6.75	CN¥9.56	x

Capital Efficiency Dashboard

This dashboard shows how efficiently ZhuZhou QianJin Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 9.50%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.92%
• Asset Turnover: 0.73x
• Equity Multiplier: 1.64x
Recent ROE (9.50%) is below the historical average (13.11%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2001	25.47%	6.16%	1.68x	2.46x	CN¥20.95 Million
2002	23.97%	6.83%	1.62x	2.17x	CN¥23.17 Million
2003	23.08%	7.29%	1.63x	1.94x	CN¥28.38 Million
2004	7.20%	7.50%	0.76x	1.26x	CN¥-17.67 Million
2005	10.35%	8.99%	0.83x	1.38x	CN¥2.02 Million
2006	11.21%	11.91%	0.73x	1.29x	CN¥7.72 Million
2007	19.85%	25.54%	0.63x	1.24x	CN¥86.16 Million
2008	15.26%	16.21%	0.76x	1.24x	CN¥44.75 Million
2009	14.17%	14.48%	0.71x	1.37x	CN¥38.51 Million
2010	9.58%	8.82%	0.87x	1.25x	CN¥-3.77 Million
2011	9.12%	6.59%	0.98x	1.41x	CN¥-8.01 Million
2012	12.44%	7.59%	0.96x	1.70x	CN¥23.56 Million
2013	12.28%	6.27%	1.04x	1.87x	CN¥22.95 Million
2014	9.37%	4.79%	0.98x	1.99x	CN¥-7.05 Million
2015	5.64%	3.80%	0.89x	1.67x	CN¥-71.72 Million
2016	8.56%	5.22%	0.94x	1.74x	CN¥-25.14 Million
2017	11.07%	6.53%	0.97x	1.75x	CN¥20.02 Million
2018	12.59%	7.67%	0.96x	1.71x	CN¥52.47 Million
2019	13.51%	8.35%	0.92x	1.75x	CN¥76.51 Million
2020	13.11%	8.19%	0.86x	1.87x	CN¥70.39 Million
2021	14.05%	8.24%	0.90x	1.89x	CN¥87.02 Million
2022	13.65%	7.51%	0.87x	2.09x	CN¥80.89 Million
2023	13.41%	8.44%	0.81x	1.96x	CN¥81.44 Million
2024	9.37%	6.36%	0.80x	1.85x	CN¥-15.47 Million
2025	9.50%	7.92%	0.73x	1.64x	CN¥-14.99 Million

Industry Comparison

This section compares ZhuZhou QianJin Pharmaceutical Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,041,443,343
Average return on equity (ROE) among peers: 10.73%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
ZhuZhou QianJin Pharmaceutical Co Ltd (600479)	CN¥3.43 Billion	25.47%	0.49x	$688.57 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$971.04 Million	5.41%	3.98x	$565.97 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$1.33 Billion	6.10%	1.68x	$359.03 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$8.39 Billion	22.09%	0.19x	$4.30 Billion
Livzon Pharmaceutical Group Inc (000513)	$3.01 Billion	11.93%	0.53x	$2.52 Billion
Wedge Industrial Co Ltd (000534)	$1.15 Billion	11.42%	1.59x	$2.41 Billion
Yunnan Baiyao Group Co Ltd (000538)	$1.42 Billion	23.64%	1.01x	$12.64 Billion
Hainan Haiyao Co Ltd (000566)	$445.29 Million	14.73%	0.90x	$715.72 Million
Tus Pharmaceutical Group Co Ltd (000590)	$347.80 Million	3.58%	0.72x	$319.94 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$905.53 Million	2.15%	1.95x	$916.75 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$22.44 Billion	6.25%	0.15x	$3.00 Billion

About ZhuZhou QianJin Pharmaceutical Co Ltd

SHG:600479 China Drug Manufacturers - Specialty & Generic

Market Cap

$688.57 Million

CN¥4.71 Billion CNY

Market Cap Rank

#10804 Global

#3010 in China

Share Price

CN¥9.56

Change (1 day)

+0.31%

52-Week Range

CN¥9.53 - CN¥11.43

All Time High

CN¥14.19